Northern Trust’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-645,282
| Closed | -$26.4M | – | 4497 |
|
|
2024
Q2 | $26.4M | Sell |
645,282
-30,272
| -4% | -$1.24M | ﹤0.01% | 1381 |
|
|
2024
Q1 | $28.6M | Buy |
675,554
+708
| +0.1% | +$29.9K | ﹤0.01% | 1350 |
|
|
2023
Q4 | $28.6M | Buy |
674,846
+79,868
| +13% | +$3.39M | 0.01% | 1370 |
|
|
2023
Q3 | $13M | Buy |
594,978
+11,700
| +2% | +$255K | ﹤0.01% | 1826 |
|
|
2023
Q2 | $18.5M | Buy |
583,278
+29,737
| +5% | +$945K | ﹤0.01% | 1636 |
|
|
2023
Q1 | $13.5M | Buy |
553,541
+15,985
| +3% | +$390K | ﹤0.01% | 1818 |
|
|
2022
Q4 | $17M | Buy |
537,556
+28,280
| +6% | +$892K | ﹤0.01% | 1639 |
|
|
2022
Q3 | $14.4M | Buy |
509,276
+7,399
| +1% | +$209K | ﹤0.01% | 1719 |
|
|
2022
Q2 | $13.3M | Buy |
501,877
+91,259
| +22% | +$2.41M | ﹤0.01% | 1816 |
|
|
2022
Q1 | $14.4M | Sell |
410,618
-16,220
| -4% | -$568K | ﹤0.01% | 1911 |
|
|
2021
Q4 | $13.8M | Buy |
426,838
+12,469
| +3% | +$404K | ﹤0.01% | 2020 |
|
|
2021
Q3 | $12.2M | Buy |
414,369
+34,588
| +9% | +$1.02M | ﹤0.01% | 2136 |
|
|
2021
Q2 | $9.73M | Buy |
379,781
+310,180
| +446% | +$7.95M | ﹤0.01% | 2380 |
|
|
2021
Q1 | $956K | Buy |
69,601
+3,796
| +6% | +$52.1K | ﹤0.01% | 3602 |
|
|
2020
Q4 | $1.09M | Buy |
+65,805
| New | +$1.09M | ﹤0.01% | 3483 |
|